The invention features 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, compositions containing them, and methods of using them as PPAR delta modulators to treat or inhibit the progression of, for example, dyslipidemia.

The invention features 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, compositions containing them, and methods of using them as PPAR delta modulators to treat or inhibit the progression of, for example, dyslipidemia.

A process for a reactive extraction and subsequent purification of organic molecules from biomass comprises extracting one or more products from the biomass using an extraction solvent to solvate the products, contacting the biomass with a reactant during the extracting, recovering the one or more products, performing ultrafiltration to remove impurities from the one or more products to produce a filtered extract, extracting oils in the filtered extract using adsorption to produce a de-oiled extract, performing transesterification or hydrolysis on the de-oiled extract, and performing adsorptive purification on the ferulic acid, coumaric acid, ferulate, coumarate, or a combination thereof. The one or more products comprise extracted organic molecules comprising a ferulate or a coumarate, and the one or more products are separated from the biomass as a liquid extract.

A process for a reactive extraction and subsequent purification of organic molecules from biomass comprises extracting one or more products from the biomass using an extraction solvent to solvate the products, contacting the biomass with a reactant during the extracting, recovering the one or more products, performing ultrafiltration to remove impurities from the one or more products to produce a filtered extract, extracting oils in the filtered extract using adsorption to produce a de-oiled extract, performing transesterification or hydrolysis on the de-oiled extract, and performing adsorptive purification on the ferulic acid, coumaric acid, ferulate, coumarate, or a combination thereof. The one or more products comprise extracted organic molecules comprising a ferulate or a coumarate, and the one or more products are separated from the biomass as a liquid extract.

A resveratrol derivative of the compound of formula I or a pharmaceutically acceptable salt thereof are effective for treating a fibrotic disease.

##STR00001##

In formula I, R.sub.1 is hydrogen or C.sub.1-C.sub.4 alkyl, R.sub.2 and R.sub.3 are each independently C.sub.1-C.sub.3 alkyl or C.sub.1-C.sub.3 deuterated alkyl, and R.sub.2 and R.sub.3 are the same or different; the C.sub.1-C.sub.4 alkyl or C.sub.1-C.sub.3 alkyl is optionally substituted with one or more substituents each independently selected from the group consisting of halogen (for example, fluorine, chlorine, bromine, iodine), methyl, hydroxyl, ethyl, amino, methoxy, and nitro; and R.sub.4 and R.sub.5 are substituted or unsubstituted C.sub.1-C.sub.3 alkyl. The fibrotic disease is selected from the group consisting of liver fibrosis, lung fibrosis, kidney fibrosis, and cardiac fibrosis.

Provided herein are compounds that are useful intermediates that may used to synthesize myeloid cell leukemia 1 protein (Mcl-1) inhibitors. Also provided are Mcl-1 inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula I,

##STR00001##

and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.

Provided herein are compounds that are useful intermediates that may used to synthesize myeloid cell leukemia 1 protein (Mcl-1) inhibitors. Also provided are Mcl-1 inhibitors, methods of their preparation, related pharmaceutical compositions, and methods of using the same. For example, provided herein are compounds of Formula I,

##STR00001##

and pharmaceutically acceptable salts thereof and pharmaceutical compositions containing the compounds. The compounds and compositions provided herein may be used, for example, in the treatment of diseases or conditions, such as cancer.

Herbicides, systems, and methods for inhibiting germination of a root parasitic plant are provided. In particular, the herbicide includes an active compound represented by Formula I. In this regard, the active compound is selected to bind to an active site of strigolactone receptors in seeds of the root parasitic plant.

Herbicides, systems, and methods for inhibiting germination of a root parasitic plant are provided. In particular, the herbicide includes an active compound represented by Formula I. In this regard, the active compound is selected to bind to an active site of strigolactone receptors in seeds of the root parasitic plant.

Compounds provided herein function as thyromimetics and have utility for treating diseases such as neurodegenerative disorders and fibrotic diseases. Pharmaceutical compositions containing such compounds are also provided, as are methods of their preparation.